ATLN
NASDAQ · Life Sciences Tools & Services
Atlantic International Corp
$0.92
-0.23 (-20.00%)
Financial Highlights (FY 2026)
Revenue
632.09M
Net Income
-86,183,725
Gross Margin
10.5%
Profit Margin
-13.6%
Rev Growth
+1,669.6%
D/E Ratio
2.45
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 10.5% | 42.5% | 42.5% | 42.5% |
| Operating Margin | -11.5% | 16.4% | 14.8% | 16.8% |
| Profit Margin | -13.6% | 9.8% | 11.0% | 12.8% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 632.09M | 137.50M | 128.72M | 150.34M |
| Gross Profit | 66.69M | 58.38M | 54.65M | 63.83M |
| Operating Income | -72,816,257 | 22.55M | 19.09M | 25.30M |
| Net Income | -86,183,725 | 13.41M | 14.17M | 19.27M |
| Gross Margin | 10.5% | 42.5% | 42.5% | 42.5% |
| Operating Margin | -11.5% | 16.4% | 14.8% | 16.8% |
| Profit Margin | -13.6% | 9.8% | 11.0% | 12.8% |
| Rev Growth | +1,669.6% | +9.2% | +17.5% | -9.6% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 25.97M | 64.08M | 61.68M | 71.70M |
| Total Equity | 10.62M | 174.87M | 149.24M | 163.17M |
| D/E Ratio | 2.45 | 0.37 | 0.41 | 0.44 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -65,695,604 | 31.52M | 29.06M | 36.12M |
| Free Cash Flow | — | 19.05M | 20.50M | 15.74M |